Evergreen Capital Management LLC Takes $274,000 Position in Select Medical Holdings Co. (NYSE:SEM)

Evergreen Capital Management LLC acquired a new stake in Select Medical Holdings Co. (NYSE:SEM) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 7,804 shares of the health services provider’s stock, valued at approximately $274,000.

Several other hedge funds also recently bought and sold shares of SEM. Hexagon Capital Partners LLC boosted its holdings in Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 645 shares during the period. Transcendent Capital Group LLC bought a new stake in Select Medical during the second quarter valued at $35,000. Canada Pension Plan Investment Board purchased a new position in Select Medical during the second quarter worth about $39,000. Fidelis Capital Partners LLC bought a new position in Select Medical in the 1st quarter worth about $47,000. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Select Medical in the 2nd quarter valued at about $60,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Trading Up 0.6 %

Select Medical stock opened at $34.67 on Friday. Select Medical Holdings Co. has a one year low of $21.28 and a one year high of $40.50. The business’s fifty day moving average is $35.26 and its 200 day moving average is $33.16. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market capitalization of $4.51 billion, a PE ratio of 16.51, a price-to-earnings-growth ratio of 2.18 and a beta of 1.42.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, August 1st. The health services provider reported $0.60 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 17.50% and a net margin of 3.91%. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period last year, the firm posted $0.61 EPS. On average, sell-side analysts predict that Select Medical Holdings Co. will post 2.03 EPS for the current year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were paid a dividend of $0.125 per share. The ex-dividend date was Wednesday, August 14th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.44%. Select Medical’s dividend payout ratio is currently 23.81%.

Analysts Set New Price Targets

SEM has been the topic of several research analyst reports. Benchmark restated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research report on Friday, September 6th. Bank of America began coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $39.00.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.